Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
McKinsey
Johnson and Johnson
Moodys
Baxter

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Fludeoxyglucose f-18 - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for fludeoxyglucose f-18 and what is the scope of patent protection?

Fludeoxyglucose f-18 is the generic ingredient in one branded drug marketed by Downstate Clincl, 3d Imaging Drug, Biomedcl Res Fdn, Brigham Womens, Cardinal Health 414, Childrens Hosp Mi, Cpdc, Decatur, Essential Isotopes, Feinstein, Hot Shots Nm Llc, Houston Cyclotron, Jubilant Draximage, Kettering Medctr, Kreitchman Pet Ctr, Lantheus Medical, Ma General Hosp, Mcprf, Mem Sloan-kettering, Methodist Hosp Res, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Northland, Petnet, Precision Nuclear, Queen Hamamatsu Pet, Shertech Labs Llc, Sofie, Spectron Mrc Llc, Trustees Univ Pa, Ucla Biomedical, Ucsf Rodiopharm, Uihc Pet Imaging, Univ Michigan, Univ Tx Md Anderson, Univ Utah Cyclotron, Weill Medcl Coll, Wi Medcl Cyclotron, and Wusm Cyclotron, and is included in forty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for fludeoxyglucose f-18. Thirty-six suppliers are listed for this compound.

Summary for fludeoxyglucose f-18
Recent Clinical Trials for fludeoxyglucose f-18

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
CHU de Quebec-Universite LavalPhase 2
ECOG-ACRIN Cancer Research GroupPhase 3
Canary FoundationPhase 2

See all fludeoxyglucose f-18 clinical trials

Pharmacology for fludeoxyglucose f-18
Synonyms for fludeoxyglucose f-18
(18)FDG
(2S,3R,4S,5S,6R)-3-fluoranyl-6-(hydroxymethyl)oxane-2,4,5-triol
(2S,3R,4S,5S,6R)-3-fluoro-6-(hydroxymethyl)oxane-2,4,5-triol
(2S,3R,4S,5S,6R)-3-fluoro-6-(hydroxymethyl)tetrahydropyran-2,4,5-triol
[18F]FDG
[F-18]-FDG
105851-17-0
18DG
18FDG
2-(fluoro-(18)F)-2-deoxy-alpha-glucopyranose
2-(Fluoro-18F)-2-deoxy-alpha-glucopyranose
2-deoxy-2-((18)F)fluoro-alpha-D-glucopyranose
2-deoxy-2-((18)F)fluoro-alpha-D-glucose
2-deoxy-2-(fluoro-(18)F)-alpha-D-glucopyranose
2-Deoxy-2-(fluoro-18f)-a-D-glucopyranose
2-Deoxy-2-fluoro-(sup 18)F-alpha-D-glucopyranose
2-deoxy-2-fluoro-alpha-D-glucopyranose
2-deoxy-2-fluoro-alpha-D-glucose
2-deoxy-2-fluoro-d-glucose 29702-43-0
2-deoxy-2-fluoro-glucose
62182-10-9
851D170
AC1L9HML
AC1L9OYT
AKOS006272016
alpha-D-Fludeoxyglucopyranose
alpha-D-Glucopyranose, 2-deoxy-2-(fluoro-(sup 18)F)-
alpha-D-Glucopyranose, 2-deoxy-2-(fluoro-18F)-
alpha-D-Glucopyranose, 2-deoxy-2-fluoro-
AN-33874
CHEBI:31617
CHEBI:49132
CHEMBL1086863
CHEMBL1092067
D01843
DB04282
F-18 FDG
Flucis
Fludeoxyglucose ((sup 18)F)
Fludeoxyglucose (18F)
Fludeoxyglucose (18F) (JAN/INN)
Fludeoxyglucose (18F)-
Fludeoxyglucose F 18
Fludeoxyglucose F 18 (TN)
Fludeoxyglucose F 18 (USP)
Fludeoxyglucose f 18 [USAN:USP]
Fludeoxyglucose F18
FLUORINE F 18 FLUORODEOXYGLUCOSE
Fluorodeoxyglucose F 18
G2F
H0QPM375HE
LS-186650
LS-187383
MOLI000964
SBT3GBX27W
SCHEMBL135994
SCHEMBL5674906
UNII-H0QPM375HE
UNII-SBT3GBX27W
WURCS=2.0/1,1,0/[a2122h-1a_1-5_2*F]/1/
ZCXUVYAZINUVJD-AHXZWLDOSA-N
ZINC3809846

US Patents and Regulatory Information for fludeoxyglucose f-18

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Feinstein FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 021870-001 Aug 19, 2005 DISCN Yes No   Start Trial   Start Trial   Start Trial
Kettering Medctr FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 204759-001 Oct 27, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
Kreitchman Pet Ctr FLUDEOXYGLUCOSE F18 fludeoxyglucose f-18 INJECTABLE;INTRAVENOUS 203942-001 Apr 11, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Moodys
Colorcon
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.